Want to contact a District of Columbia Sustiva attorney? ...Get a free case evaluation from one of our District of Columbia Sustiva attorneys now.

Sustiva - MSN Newsfeeds

Patent busting moves ahead
Bangkok Post - Thailand approved compulsory licensing to bypass patents on anti-Aids and heart drugs Efavirenz, Kaletra and Plavix last November and January, and the Government Pharmaceutical Organisation has begun importing the generic version of Efavirenz from a ...
Politics and Policy | New Trade Agreement Language To Allow Developing ...
Kaisernetwork.org - According to the findings, 57% of people said they supported Brazil's decision to issue a compulsory license for Merck 's antiretroviral efavirenz and provide a lower-cost generic version to residents, while 20% of respondents said they oppose the ...
ITSSD: Brazilians' Private Property Rights Threatened By Government's ...
Forbes - ... appearing in Washington, DC and Porto Alegre, Brazil, international business, trade and regulatory attorney Lawrence Kogan reviews the multiple bases offered by the Brazilian government for its illegal 'taking' of the American HIV/AIDS drug Efavirenz ...
Museum Portrays Medicine Through Art
Newsday - Case in point is Mark Quinn's "Silvia Petretti -- Sustiva, Tenofivir, 3TC (HIV)," a sculpture of a woman named Silvia Peretti who was HIV positive. As Quinn combined wax and polymer to create a cast of her body, he added one dose of the retroviral ...
Museum Portrays Medicine Through Art
Washington Post - Case in point is Mark Quinn's "Silvia Petretti _ Sustiva, Tenofivir, 3TC (HIV)," a sculpture of a woman named Silvia Peretti who was HIV positive. As Quinn combined wax and polymer to create a cast of her body, he added one dose of the retroviral ...
Main article: Infant feeding policy debated at the Conference on ...
Aidsmap - Therapeutic concentrations of efavirenz, Kaletra , could be difficult to achieve in some children, with or without rifampicin Read More >> CROI: Large Zambian study finds early abrupt weaning of HIV-exposed infants does not improve HIV-free survival ...
A gathering storm
Financial Express - At the end of last year the Thai government stunned the drugs industry when it said it would overrule international patents for Efavirenz, an anti-retroviral drug made by Merck, an American firm, and switch to a Thai-made generic copy at half the ...
U.S. firm, Thailand face-off in HIV drug patent feud
East Valley Tribune - In early May, Brazil issued a compulsory license for Stocrin, a first-line AIDS medication made by Merck & Co., claiming a generic version known as efavirenz would save $240 million by 2012. Brazil has threatened to override patents on HIV drugs ...
Greystar Says Colombia Gold Project to Cost Less Than Estimated
Bloomberg - June 1 (Bloomberg) -- Greystar Resources Ltd., a precious- metals miner in Colombia, said it can produce gold and silver from its Angostura pit in Colombia for a third less than the estimate provided by an independent surveyor. The company, based in ...
Ranieri Quits as Parma Coach, Prepares for Manchester City
Bloomberg - June 1 (Bloomberg) -- Former Chelsea manager Claudio Ranieri quit as coach of Italian soccer team Parma yesterday, paving the way for a move to England's Manchester City. Deposed Thai Prime Minister Thaksin Shinawatra is trying to buy the Premiership ...
Thai Government To Issue Compulsory Licenses For Two More Drugs ...
Medical News Today - The Thai government in November 2006 and January issued compulsory licenses to produce lower-cost versions of Merck 's antiretroviral Efavirenz and Abbott Laboratories ' Kaletra, respectively. Since then, the government and drug companies have continued ...
Free Weekly Newsletter
Latin Business Chronicle - Brazilian President Luiz Inacio Lula da Silva on Friday signed a law to create a 'compulsory license' allowing the government to break drug company Merck's patent on its Efavirenz AIDS drug and purchase a generic version of the drug from other ...
Oliveria: Brazil's AIDS policy works
University Daily Kansan - Last Friday, Brazilian President Luiz Inácio Lula da Silva broke the patent of the anti-AIDS drug efavirenz. Although there are many things in the scandal-plagued Lula administration that deserve criticism, this action should be commended as a noble ...
Drug Access | Abbott Offers To Sell Antiretroviral Aluvia at Reduced ...
Kaisernetwork.org - The Thai government in November 2006 and January issued compulsory licenses to produce lower-cost versions of Merck 's antiretroviral Efavirenz and Kaletra, respectively. Since then, the government and drug companies have continued negotiations ( Kaiser ...
Oliveria: Brazil's AIDS policy works
University Daily Kansan - Last Friday, Brazilian President Luiz Inácio Lula da Silva broke the patent of the anti-AIDS drug efavirenz. Although there are many things in the scandal-plagued Lula administration that deserve criticism, this action should be commended as a noble ...
Bill Clinton Announces AIDS Drug Deals
Associated Press - The reduced-price, once-daily pill combines the drugs tenofovir, lamivudine and efavirenz. Clinton said the new price of $339 per patient per year would be 45 percent lower than the current rate available to low-income countries and 67 percent less ...
COMPULSORY LICENSING
Nation - Thailand - In November last year, the Thai officials invoked compulsory licensing on Efavirenz, an Aids-treatment drug owned by Merck & Co. By doing so, it suspended patent protection and allowed the Government Pharmaceutical Organisation to produce a generic ...
Thailand Turns Giant Pharma Killer
Common Dreams - Thailand first broke the patent on the anti-retroviral (ARV) drug Efavirenz produced by U.S. pharmaceutical company Merck Sharp and Dohme last November, and went on to do the same with Kaletra, another anti-HIV/AIDS drug from U.S. pharma major Abbott ...
Drug Access | GlaxoSmithKline, Brazil Expected To Sign Deal on ...
Kaisernetwork.org - The deal comes one week after Brazilian President Luiz Inacio Lula da Silva issued a compulsory license to produce a lower-cost, generic version of Merck 's antiretroviral Efavirenz (Radowitz, Dow Jones , 5/10). World Trade Organization regulations ...
FTA: The unstated reason for the watch list
Bangkok Post - ... change, which could open the kingdom up to retaliatory trade measures such as loss of generalised system of preferences (GSP) privileges, was Thailand's decision to award compulsory licensing last November on the anti-HIV/Aids medication Efavirenz ...
Want to contact a District of Columbia Sustiva attorney? ...Get a free case evaluation from one of our District of Columbia Sustiva attorneys now.

Pages:   1   2   3   4   5   6   ...   Next

AddThis Social Bookmark Button

 

Need A Sustiva Attorney?

First Name Last Name Email Address State
Has Your Health Been Negatively Affected?

Please Describe the Injury
Click to Ask a Question

Your Friend's Email Address

Your Email Address

Type a Message (optional)


 

Need A Sustiva Lawyer?

First Name Last Name Email Address State
Has Your Health Been Negatively Affected?

Please Describe the Injury
Click to Ask a Question

 

Close (x)

Looking for an Attorney?


Please type your question:

Close (x)

logo Find Legal Help for Your Sustiva Case - Submit Your Information Below

Do you need legal assistance with your Sustiva case?
LegalView may be able to help.


Submit your information below for a free, no-cost evaluation.

We'll submit your information to one of our partner firms.
LegalView's partners represent clients throughout the United States, for a very wide range of legal issues. Submit your information now, to see if one of LegalView's partners can help!

* Indicates Required Fields

First name *
Last name *
Email Address *
Phone Number *
()  -

State *
Legal Issue * DrugWatch: Sustiva Change
Was There an Injury?
Please Describe The Injury

DISCLAIMER and STATEMENT OF NON-CONFIDENTIALITY

By submitting this form, you agree that completing the above is not intended to create an attorney-client relationship.

Disclosure

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website [more...]

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website, LegalWebMedia.com will submit your information to the law firms that pay for this group advertising and to respond to your requests for information concerning legal services in their assigned local areas. If there is no sponsoring firm in your state, your inquiry will be submitted to one of the sponsoring law firms on a predetermined, rotating basis. If the sponsoring law firm accepts your case, it will associate with licensed attorneys practicing in your state, if required; the sponsoring law firm may also contact other law firms to see if they may be able to assist.

The information provided by the LegalView.com and LegalWebMedia.com websites is for advertising and informational purposes and should not be considered as legal advice from the sponsoring attorneys. The websites contain general information and may not reflect current legal developments, verdicts, or settlements. LegalView.com contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Any person viewing or receiving information from these websites should not act or refrain from acting on the basis of any such information without first seeking appropriate legal advice from an attorney in your area. Legal WebTV Network, LLC expressly disclaims any liability with respect to actions taken or not taken by the recipient based on any or all of the information or contents contained in these websites.

Any information sent to Legal WebTV Network LLC through this website is done using standard Web encryption techology. LegalView.com will exercise all reasonable care, within technological limits, to protect the confidentiality of any information submitted via Internet e-mail or through this website. By accessing this website, you may be seeking an attorney to represent you or legal advice. However, none of the sponsoring attorneys represent you yet.

The choice of a lawyer is an important decision and should not be based solely upon advertisements.

Any transmission of information, whether via Internet e-mail or through the website, is solely for evaluation purposes by the sponsoring law firms and their associates. The transmission of any information to any attorney sponsoring advertising on LegalView.com or LegalWebMedia.com does not create an attorney-client relationship between the sender and any recipient. An attorney-client relationship can only be created by a written, signed-fee agreement entered into with an attorney. The sponsoring attorneys will treat your information as a confidential communication for the purpose of obtaining legal services or legal advice.

For more information about the sponsoring law firms, please click here.

This form is secure and encrypted. More information about secure forms and your privacy here.